Evidence map›Paper›PMID 35766512›Full record

ArticleMicrobiology spectrum2022

CRISPR-Cas9 Toolkit for Genome Editing in an Autotrophic CO

Jie Li, Liuyang Zhang, Qing Xu, Wenting Zhang, Zhihua Li, Lei Chen, Xiuzhu Dong

Abstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Dissection ofmBio · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Teaching old dogs new tricks: genetic engineering methanogens.Applied and environmental microbiology · 2024
    Review
  8. Mechanisms of microbial co-aggregation in mixed anaerobic cultures.Applied microbiology and biotechnology · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Scale-up of biomass production byFrontiers in microbiology · 2022
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jie Li *State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.ORCID 0000-0002-2773-6806
Liuyang Zhang *Center for Life Sciences, School of Life Sciences, Yunnan University, Kunming, China.
Qing Xu *Laboratory of Synthetic Microbiology, School of Chemical Engineering & Technology, Tianjin Universitygrid.33763.32, Tianjin, China.
Wenting ZhangState Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Zhihua LiState Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Lei ChenLaboratory of Synthetic Microbiology, School of Chemical Engineering & Technology, Tianjin Universitygrid.33763.32, Tianjin, China.
Xiuzhu DongState Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.ORCID 0000-0002-6926-5459

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The CRISPR-Cas9 system is a robust genome editing tool that is widely applied in eukaryotes and bacteria. However, use of this technique has only been developed for one species of

Indexed as

CRISPR-Cas SystemsGene EditingArchaeaCarbon DioxideNucleotidesCarbon DioxideNucleotidesarchaeaCO2 fixingCRISPR-Cas9geneticsgenome editingMethanococcus maripaludismethanogenic archaeon

Identifiers

PMID35766512
PMCPMC9430280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.